Looking to sell Ring Therapeutics stock or options?
Contact usRing Therapeutics is a developer of medical gene therapeutics, utilizing a unique viral vector platform to enhance DNA-based treatments. Their platform is designed to target specific areas of disease with tissue and cellular specificity. The company's scope extends beyond gene replacement, covering other areas such as genetic disorders, ophthalmology, oncology, and metabolic disorders. This enables healthcare companies to offer therapeutics that use a diverse range of modalities and mechanisms, and reach tissues and organs previously inaccessible.
The Invus Group, CJ Investment, Altitude Life Science Ventures, UPMC Enterprises, Flagship Pioneering, Alexandria Venture Investments, Kyowa Kirin, Partners Investment, T. Rowe Price Group.